Hercules Capital reports developments for a specialty finance company focused on senior secured venture growth loans to venture capital-backed and select private equity-backed companies in technology, life sciences and related growth industries. News commonly covers debt and equity commitments, fundings, portfolio activity, earnings results, net investment income, leverage, liquidity and cash distributions.
The company also reports governance and capital-market developments tied to its public securities, including its NYSE-listed common stock and 6.25% Notes due 2033 under the symbol HCXY. Recurring updates include annual meeting materials, executive leadership changes, credit ratings, adviser-subsidiary activity and external funds managed through Hercules Adviser LLC.
Hercules Capital, Inc. (NYSE: HTGC) has completed a public offering of $325 million in 2.625% unsecured notes due September 16, 2026. The proceeds will be used to repurchase existing asset-backed notes, fund investments in debt and equity securities, and for general corporate purposes. The Notes, rated Baa3 and BBB+ by Moody's and Kroll Bond Rating Agency respectively, offer semiannual interest payments. Hercules continues to lead in providing growth loans to high-growth, venture-backed companies, having committed over $12 billion since its inception in December 2003.
Hercules Capital, Inc. (NYSE: HTGC) has priced a public offering of $325 million in 2.625% notes due September 2026. The unsecured notes will deliver interest semiannually and can be redeemed at the Company’s option. The net proceeds will be used to repurchase asset-backed notes, fund investments in debt and equity securities, and for general corporate purposes. The offering's completion is subject to customary closing conditions.